AI Bias Analysis
4 models · Takes ~15 seconds
(MedPage Today) -- The B-cell depleting agent obinutuzumab (Gazyva) was superior to the immunosuppressant tacrolimus in inducing remissions in primary membranous nephropathy, the global phase III MAJESTY trial showed. By week 104, 37% of patients...
Source
MedPage Today
Opens original article in a new tab
(MedPage Today) -- LONDON -- Two investigational drugs for lupus with encouraging primary phase II results yielded more good news from follow-on studies, reports here indicated. The Toll-like receptor (TLR) inhibitor enpatoran showed no diminution...
(MedPage Today) -- Members of the American Diabetes Association (ADA) were escorted by police out of the convention center in New Orleans during the organization's annual meeting on Friday as they handed out copies of an editorial criticizing Trump...
(MedPage Today) -- On June 11, the largest FIFA World Cup in history kicks off across 16 cities in the U.S. (11 cities), Canada, and Mexico. Over 5 million fans from around the globe will pack stadiums, fan zones, and city streets through mid-July...
(MedPage Today) -- In this MedPage Today webinar, Editor-in-Chief Jeremy Faust, MD, speaks with Jeremy Konyndyk, president of Refugees International and former U.S. Agency for International Development (USAID) official who helped lead the U.S...
